Biotech

All Articles

ReNeuron leaving purpose swap after overlooking fundraising objective

.ReNeuron has signed up with the lengthy listing of biotechs to leave London's AIM securities market...

MBX apply for IPO to take opposition to Ascendis right into stage 3

.MBX Biosciences has added to the latest flurry of IPO filings. The biotech, which filed its documen...

FDA grows probe in to Lykos' MDMA trials: WSJ

.For Lykos Rehabs and the company's prospective MDMA-assisted treatment for post-traumatic stress di...

Gene editor Volume giving up 131 workers

.Just times after gene publisher Tome Biosciences declared concealed functional cuts, a clearer phot...

Repare gives up 25% of workers as biotech halts preclinical R&ampD

.Repare Rehab is giving up an one-fourth of its own staff as the oncology biotech downsize its own p...

J &amp J apply for FDA authorization of $6.5 B autoimmune drug

.Johnson &amp Johnson has taken another step towards recognizing a yield on its $6.5 billion nipocal...

Gain's period 1 succeed paves method to confirm Parkinson's medicine's worth

.Increase Rehabs has specified its own sights on proving the performance of its Parkinson's ailment ...

Actinogen documents new period 2 records to recover clinical depression medicine

.Actinogen Medical's chances-- and also sell rate-- have actually recoiled somewhat coming from earl...

Pfizer and also Main add Quotient to multibillion-dollar equation

.Main Pioneering and also Pfizer have actually added Quotient in to their 10-program relationship, i...

Bayer markers $547M contract to push boundaries of noncoding RNA

.Bayer execs were actually keen to stress and anxiety to Intense this summer season that the German ...